Urinary bladder disorders

Sep 28, 2017

Cogentix Medical Makes $2 Million Investment in Israeli Company Developing Innovative and Novel Device for Delivery of Drugs to the Bladder

Sep 13, 2017

Cogentix Medical Announces Cahaba GBA, LLC Extends Coverage for Urgent PC Maintenance Therapy

Sep 13, 2017

IC/BPS Patients Refuse to Suffer in Silence

Sep 12, 2017

U.S. FDA Accepts for Review Astellas' Supplemental New Drug Application for mirabegron for Use in Combination with solifenacin succinate 5 mg for the Treatment of Overactive Bladder

Sep 01, 2017

Urinary Catheters Market Worth 2.19 Billion USD by 2022

Aug 03, 2017

Global Overactive Bladder Treatment Market to Reach USD 4.19 Billion by 2022 - Driven by the Development of New Therapies to Treat Bladder Overactivity

Jul 27, 2017

Overactive Bladder Treatment Market Worth 4.19 Billion USD by 2022

Jun 06, 2017

Roivant Sciences Launches Urovant to Develop Innovative Therapies in Urology